Peregrine-led consortium to invest NIS 300m in incubator cos
The consortium includes Bristol-Myers Squibb (BMS), BD (Becton Dickinson), Elbit Systems, Tel Aviv University, Ben-Gurion University of the Negev, and Shaare Zedek Medical Center.
Stay updated with breaking news from Incentive Incubator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The consortium includes Bristol-Myers Squibb (BMS), BD (Becton Dickinson), Elbit Systems, Tel Aviv University, Ben-Gurion University of the Negev, and Shaare Zedek Medical Center.
The new members of Peregrine’s Incentive Incubator include global pharmaceutical giant Bristol-Myers Squibb (BMS), medical devices and diagnostics company BD (Becton Dickinson and Company), Elbit Systems, and institutions such as Tel Aviv University, Ben-Gurion University of the Negev, and Shaare Zedek Medical Center
The 5 tech incubators will operate in the fields of health, bio-convergence, climate, food tech, and space.
Peregrine helped the company develop transcatheter mitral and tricuspid valves that are now entering clinical trials
/PRNewswire/ -- Peregrine Ventures, a leading investment firm dedicated to supporting life changing healthcare opportunities, today announced its USD 300...